Why Moderna’s 177% Rally Is Just the Beginning: The Cancer Vaccine Tsunami That Will Redefine Big Pharma
Moderna's 177% surge signals a structural shift from COVID to cancer. With mRNA-4157 showing a 44% reduction in recurrence, the platform's adaptability across tumor types...
